IB
Imagion Biosystems Limited
IBXXF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $9.05M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
16.7% downside
Current Price
$0.012
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IBXXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 882.39%
Asset turnover 0.00x
ROA 210.82%
Debt
2 /100
High Current ratio 0.48x
Int. coverage -4.23x
Debt/Equity N/A
Stability
22 /100
Unstable Beta -0.21x
Profitable years 0
Rev. volatility 82.45%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IBXXF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Robert Romeo Proulx
Employees
11
Headquarters
Melbourne